DNA-capped nanoparticles designed for doxorubicin drug delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Gold nanoparticles (AuNP) offer a versatile platform for drug delivery.
• DNA serves as a biocompatible and programmable capping agent for nanoparticles.
• Targeted delivery of chemotherapeutic agents like doxorubicin (DOX) can improve efficacy and reduce side effects.

Purpose of the Study:

• To load the anticancer drug doxorubicin (DOX) onto DNA-capped gold nanoparticles (AuNP).
• To characterize the DOX-DNA-AuNP interaction and drug loading efficiency.
• To confirm the drug release capacity of the nanocarrier for potential targeted delivery.

Main Methods:

• Synthesis of DNA-capped gold nanoparticles (AuNP).
• Loading of doxorubicin (DOX) onto the DNA-AuNP constructs.
• Characterization of drug loading using DNA melting temperature, AuNP plasmon resonance, and hydrodynamic radius measurements.
• Assessment of drug release capability.

Main Results:

• Successful loading of doxorubicin onto DNA-capped gold nanoparticles was achieved.
• Drug binding was quantitatively confirmed by shifts in DNA melting temperature, AuNP plasmon resonance maximum, and hydrodynamic radius.
• The [DOX]/[DNA] ratio was optimized to maximize drug loading.
• The capacity for drug release to target DNA was validated.

Conclusions:

• DNA-capped gold nanoparticles provide an effective platform for doxorubicin (DOX) loading.
• The characterized nanocarrier demonstrates potential for targeted cancer drug delivery.
• Further in vivo studies are warranted to evaluate therapeutic efficacy and safety.